Diphtheria/Tetanus Toxoid combined vaccine (Seqirus)
- Generic Name
- Diphtheria/Tetanus Toxoid combined vaccine (Seqirus)
A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases
- First Posted Date
- 2020-08-21
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 108
- Registration Number
- NCT04523207
- Locations
- 🇺🇸
Urological Research Network, Hialeah, Florida, United States
🇺🇸Arkansas Urology, Little Rock, Arkansas, United States
🇺🇸MidLantic Urology, Bala-Cynwyd, Pennsylvania, United States
National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
- Conditions
- Prostate Cancer Metastatic
- Interventions
- First Posted Date
- 2019-09-11
- Last Posted Date
- 2020-02-12
- Lead Sponsor
- Peter Busch Østergren
- Target Recruit Count
- 20
- Registration Number
- NCT04086290
- Locations
- 🇩🇰
Herlev and Gentofte Hospital, Herlev, Denmark
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
- Conditions
- Prostate CancerCancer Of ProstateProstate NeoplasmsProstatic CancerNeoplasms of Prostate
- Interventions
- Radiation: Prostate bed with integrated boostRadiation: Prostate bed irradiation onlyDiagnostic Test: Whole Body Bone ScanDiagnostic Test: 18F-NaF PET ImagingDiagnostic Test: CTDiagnostic Test: mpMRI
- First Posted Date
- 2018-01-03
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 30
- Registration Number
- NCT03388619
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer
- First Posted Date
- 2016-11-23
- Last Posted Date
- 2024-04-05
- Target Recruit Count
- 61
- Registration Number
- NCT02972060
- Locations
- 🇧🇪
Hopitaux Universitaires Bordet-Erasme - Hopital Universitaire Erasme, Brussels, Belgium
🇪🇸Hospital Universitario Virgen De La Victoria, Malaga, Spain
🇫🇷Gustave Roussy, Villejuif, France
Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2016-08-15
- Last Posted Date
- 2021-07-07
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 128
- Registration Number
- NCT02867020
- Locations
- 🇧🇷
Beneficiencia Portuguesa de São Paulo/Hospital São José, São Paulo, Brazil
🇧🇷Hospital Erasto Gaertner, Curitiba, Paraná, Brazil
🇧🇷IBCC, São Paulo, Brazil
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
- Conditions
- Major Depression Disorder
- Interventions
- First Posted Date
- 2015-03-27
- Last Posted Date
- 2017-08-10
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 132
- Registration Number
- NCT02400346
- Locations
- 🇫🇮
FI003, Oulu, Finland
🇩🇪DE001, Schwerin, Germany
🇩🇪DE008, Berlin, Germany
Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy
- First Posted Date
- 2013-12-16
- Last Posted Date
- 2015-12-29
- Target Recruit Count
- 61
- Registration Number
- NCT02012218
- Locations
- 🇺🇸
Goldpoint Clinical Research, Indianapolis, Indiana, United States
🇺🇸St. Louis Clinical Trials, St. Louis, Missouri, United States
🇺🇸Behavioral Medical Research of Staten Island, Staten Island, New York, United States
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2013-04-24
- Last Posted Date
- 2017-08-09
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 1986
- Registration Number
- NCT01838681
- Locations
- 🇺🇦
UA007, Kherson,Vil. Stepanivka, Ukraine
🇺🇦UA005, Lviv, Ukraine
🇩🇪DE004, Nuernberg, Germany
The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer
- First Posted Date
- 2011-12-08
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT01487902
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
- First Posted Date
- 2011-10-06
- Last Posted Date
- 2015-11-06
- Target Recruit Count
- 1036
- Registration Number
- NCT01447576
- Locations
- 🇺🇸
Artemis Institute for Clinical Research, San Diego, California, United States
🇺🇸Goldpoint Clinical Research, LLC, Indianapolis, Indiana, United States
🇺🇸Oregon Center for Clinical Investigations, Inc., Portland, Oregon, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.